These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C, Franquin JC. Int J Radiat Oncol Biol Phys; 1997 Jul 01; 38(4):697-703. PubMed ID: 9240635 [Abstract] [Full Text] [Related]
4. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. El-Sayed S, Nabid A, Shelley W, Hay J, Balogh J, Gelinas M, MacKenzie R, Read N, Berthelet E, Lau H, Epstein J, Delvecchio P, Ganguly PK, Wong F, Burns P, Tu D, Pater J. J Clin Oncol; 2002 Oct 01; 20(19):3956-63. PubMed ID: 12351592 [Abstract] [Full Text] [Related]
6. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Ryu JK, Swann S, LeVeque F, Scarantino CW, Johnson D, Chen A, Fortin A, Pollock J, Kim H, Ang KK. Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):643-50. PubMed ID: 17293228 [Abstract] [Full Text] [Related]
10. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Bentzen SM, Saunders MI, Dische S, Bond SJ. Radiother Oncol; 2001 Aug 01; 60(2):123-35. PubMed ID: 11439207 [Abstract] [Full Text] [Related]
18. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients. Sangthawan D, Phungrassami T, Sinkitjarurnchai W. J Med Assoc Thai; 2013 Jan 01; 96(1):69-76. PubMed ID: 23720981 [Abstract] [Full Text] [Related]
19. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Antonadou D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas N. Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):739-47. PubMed ID: 11849797 [Abstract] [Full Text] [Related]